Evidence mapPaperPMID 40160337Full record

ArticleClinical epidemiology2025

The Mediation Role of Insulin Resistance and Chronic Systemic Inflammation in the Association Between Obesity and NAFLD: Two Cross-Sectional and a Mendelian Randomization Study.

Xiaoyin Huang, Qianni Chen, Qingling Su, Jiamin Gong, Liqin Wu, Liangguang Xiang, Wanxin Li, Jun Chen, Hongwei Zhao, Wuqing Huang and 2 more

Abstract read
In one paragraph

Article in Clinical epidemiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Xiaoyin Huang *Department of Epidemiology and Health Statistics, Fujian Medical University, Fuzhou, People's Republic of China.ORCID 0009-0008-4760-7164
Qianni Chen *Department of Ultrasonography, Fuqing City Hospital Affiliated to Fujian Medical University, Fuqing, People's Republic of China.ORCID 0009-0005-9978-366X
Qingling Su *Department of Epidemiology and Health Statistics, Fujian Medical University, Fuzhou, People's Republic of China.
Jiamin GongDepartment of Epidemiology and Health Statistics, Fujian Medical University, Fuzhou, People's Republic of China.
Liqin WuDepartment of Ultrasonography, Fuqing City Hospital Affiliated to Fujian Medical University, Fuqing, People's Republic of China.
Liangguang XiangDepartment of General Surgery, Fuqing City Hospital Affiliated to Fujian Medical University, Fuqing, People's Republic of China.
Wanxin LiDepartment of Epidemiology and Health Statistics, Fujian Medical University, Fuzhou, People's Republic of China.
Jun ChenDepartment of Epidemiology and Health Statistics, Fujian Medical University, Fuzhou, People's Republic of China.
Hongwei ZhaoDivision of Occupational and Environmental Health, University of Utah, Salt Lake City, UT, USA.
Wuqing HuangDepartment of Epidemiology and Health Statistics, Fujian Medical University, Fuzhou, People's Republic of China.ORCID 0000-0002-7616-8622
Shanshan DuInstitute of Population Medicine, Fujian Medical University, Fuzhou, People's Republic of China.
Weimin YeDepartment of Epidemiology and Health Statistics, Fujian Medical University, Fuzhou, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: We aimed to identify the association between obesity and nonalcoholic fatty liver disease (NAFLD) and to quantify the mediating effects of insulin resistance (IR) and chronic inflammation through observational studies and Mendelian randomization (MR). Patients and Methods: In the current study, three IR-related indicators and three indicators of inflammation were included. The individual and combined mediated effects of IR and inflammation in the association between obesity and NAFLD were investigated in two cross-sectional studies, the Fuqing Cohort from China and the National Health and Nutrition Examination Survey (NHANES). Total, direct, and indirect effects were estimated through direct counterfactual imputation estimation, and the proportion of mediating effects was calculated. We applied a two-step MR to determine the causal mediating role of IR and chronic inflammation in the pathway between obesity and NAFLD by using single nucleotide polymorphisms as instrumental variables to predict obesity, IR, and inflammation genetically. Results: In the Fuqing Cohort, all obese phenotypes were associated with an elevated NAFLD risk. Moreover, indicators of IR such as homeostatic model assessment of insulin resistance (HOMA-IR) and indicators of inflammation such as C-reactive protein (CRP) were significantly and positively associated with NAFLD risk. Individuals with obesity had significantly higher levels of IR and inflammation indicators compared to non-obese individuals. The indirect proportions of insulin and HOMA-IR accounted for 50.97-66.72% in the associations between obese phenotypes and NAFLD risk, while the proportions of inflammation indicators were < 14%. Similar results were observed in the NHANES analysis. In the MR analysis, the indirect effects of HOMA-IR and CRP were statistically significant with a greater mediated proportion explained by HOMA-IR than CRP. Conclusion: Through two population-based studies and MR, we found the causal mediation roles of IR and inflammation in the association between obesity and NAFLD, in which HOMA-IR and CRP showed stable, significant mediation effects. Furthermore, HOMA-IR showed a higher mediation effect than CRP. We emphasize the vital role of HOMA-IR in NAFLD monitoring.

Indexed as

inflammationinsulin resistancemediation analysisMendelian randomizationNAFLD

Identifiers

PMID40160337
PMCPMC11952067

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.